Ordering
Available Variants5 mg
CHA.87079-5mg
Price
€468.00
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
5 mg | CHA.87079-5mg | €468.00 |
≥98% (HPLC), OTR antagonist, powder
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| Empirical Formula (Hill Notation) | C26H42O5N4S2 · HCl |
|---|---|
| CAS Number | 160312-62-9 |
| Molecular Weight | 591.23 |
| UNSPSC Code | 51111800 |
| PubChem Substance ID | 24278804 |
| NACRES | NA.77 |
| MDL number | MFCD09753328 |
| Assay | ≥98% (HPLC) |
| Form | powder |
| Quality level | 100 |
Safety Information Handling visibility
| Storage Class | 11 - Combustible Solids |
|---|---|
| wgk | WGK 3 |
| flash_point_f | Not applicable |
| flash_point_c | Not applicable |
| ppe | Eyeshields, Gloves, type N95 (US) |
Technical Overview & Applications Use-case context
L-368,899, also known by its CAS identifier 160312-62-9, is a synthetic compound that has been investigated for its potential therapeutic applications. This molecule exhibits a distinct chemical structure, which confers upon it unique pharmacological properties. Research has focused on the compounds ability to interact with specific biological targets, modulating their activity in a manner that may be beneficial for the treatment of certain diseases. The mechanism of action of L-368,899 involves the selective inhibition of key enzymes or receptors, leading to a cascade of downstream effects that ultimately contribute to its therapeutic efficacy. Further studies are necessary to fully elucidate the properties and potential uses of L-368,899, as well as to assess its safety and tolerability in various patient populations. Ongoing investigations aim to explore the compounds clinical potential and optimize its development as a therapeutic agent.
